Urinary Tract Infections in General Practice: Diagnostic strategies, bacteriology, and treatment options for multi-resistant bacteria
Metadata
Show metadataAppears in the following Collection
Abstract
Urinary tract infections are commonly handled in primary care. The thesis explored diagnostic strategies and bacteriology of uncomplicated urinary tract infections. A possible narrow-spectrum antibiotic treatment for urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing E. coli was also evaluated. The data were collected by reviewing medical records, performing structured interviews and using self-report questionnaires. A validated and standardised clinical registration form was found to be a safe method to identify women with uncomplicated urinary tract infections who were likely to respond to antibiotic treatment. Stronger symptoms did not correlate with significant bacteriuria at presentation or protracted duration of symptoms following empiric treatment. However, strong symptoms could still be an indication for immediate antibiotics due to discomfort. Nitrofurantoin and pivmecillinam were found to be appropriate first choice agents for empiric treatment of uncomplicated urinary tract infections, and increased consumption of pivmecillinam had not caused marked increase in resistance rates for E. coli. ESBL producing isolates demonstrated marked co-resistance to several oral treatment options. However, pivmecillinam treatment in dosage of 400 mg x 3 was deemed a viable treatment option for community acquired urinary tract infections caused by ESBL producing E. coli. The findings suggest that a commonly used, narrow spectrum antibiotic can be used as an oral treatment option for multi-resistant bacteria causing urinary tract infections. This can possibly avoid hospitalisation of affected persons and reduce future resistance rates.List of papers
Paper 1: Bollestad M, Grude N, Lindbaek M. A randomised controlled trial of a diagnostic algorithm for symptoms of uncomplicated cystitis at an out-of-hours service. Scand J Prim Health Care 2015;33:57-64. DOI: 10.3109/02813432.2015.1041827. The article is included in the thesis. Also available at: https://doi.org/10.3109/02813432.2015.1041827 |
Paper 2: Bollestad M, Vik I, Grude N, Blix HS, Brekke H, Morten Lindbaek. Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001-2015. Brit J Gen Pract Open 2017 DOI: 10.3399/bjgpopen17X101145. The article is included in the thesis. Also available at: https://doi.org/10.3399/bjgpopen17X101145 |
Paper 3: Bollestad M, Vik I, Grude N, Lindbaek M. Predictors of symptom duration and bacteriuria in uncomplicated urinary tract infection. Scand J Prim Health Care. 2018;3:1-9. DOI: 10.1080/02813432.2018.1499602. The article is included in the thesis. Also available at: https://doi.org/10.1080/02813432.2018.1499602 |
Paper 4: Bollestad M, Grude N, Solhaug S, Raffelsberger N, Handal N, Nilsen HJ, Romstad M, Emmer A, Tveten Y, Soeraas A, Jenum P, Jenum S, Moeller-Stray J, Weme E, Lindbaek M, Simonsen GS. Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multi-centre, observational cohort study. J Antimicrob Chemother. 2018;73:2503-2509. DOI: 10.1093/jac/dky230. The article is not available in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1093/jac/dky230 |